• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of Class 1 Recall final press releases approved by OE for posting to the FDA.gov website within 24 hours of receipt

Dictionary: There are many offices involved in the process of posting a firm’s Class 1 recall press release on FDA.gov. A final press release is received by the District and sent to OE for approval and posting. Once OE receives the final press release from the District, it is reviewed by OE and sent to ORA web team for formatting. The formatted version is sent back to OE for approval. Once approved, the ORA web team is notified by OE and posts the press release to FDA.gov. OE will measure the time from OE’s receipt of the final draft from the District until OE notifies the ORA web team of the approval for posting with the goal of 100% completed within 24 hours. The actual posting of the release to the website is not in OE’s control and may be affected by IT issues and therefore will not be included in this timeframe. OE’s goal is to ensure it meets its responsibilities in a timely manner. OE will document the reason(s) for any press releases received and not approved for posting within 24 hours and will take corrective action as needed.

Information is current as of February 12, 2013.

Fiscal Year - 2012

Skip graphic and jump to text data

Oct 2011100100
Nov 2011100100
Dec 2011100100
Jan 2012100100
Feb 2012100100
Mar 2012100100
Apr 2012100100
May 2012100100
Jun 2012100100
Jul 2012100100
Aug 2012100100
Sep 2012100100


Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.